BRIEF published on 08/12/2025 at 07:05, 1 year ago SCHOTT Pharma Reports Steady Q3 2025 Results Innovation SCHOTT Pharma High-value Solutions Drug Containment Q3 2025 Results
PRESS RELEASE published on 08/12/2025 at 07:00, 1 year ago SCHOTT Pharma delivers solid final third-quarter results SCHOTT Pharma reports solid Q3 2025 results with 1% revenue growth, 32.4% EBITDA margin, and strategic innovations Revenue Growth EBITDA Margin SCHOTT Pharma Innovations Q3 2025 Results
BRIEF published on 08/05/2025 at 10:00, 1 year ago SCHOTT Pharma's Q3 2025 Highlights and FY 2025 Outlook Revenue Growth EBITDA Margin Financial Outlook Q3 2025 High Value Solutions
BRIEF published on 08/05/2025 at 09:58, 1 year ago SCHOTT Pharma Updates FY 2025 Revenue and EBITDA Guidance Financial Results Revenue Growth EBITDA Margin SCHOTT Pharma FY 2025 Guidance
PRESS RELEASE published on 08/05/2025 at 09:55, 1 year ago SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance SCHOTT Pharma reports Q3 2025 revenues up 3% yoy at EUR 256m and gives FY 2025 guidance with EBITDA expected to be around 28.0%. Full financial results to be published on August 12, 2025 Revenues EBITDA SCHOTT Pharma Q3 2025 FY 2025 Guidance
PRESS RELEASE published on 08/05/2025 at 09:53, 1 year ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin SCHOTT Pharma AG & Co. KGaA specifies FY 2025 guidance for revenue growth and EBITDA margin, expecting 6.0% organic revenue growth and 28.0% EBITDA margin Revenue Growth EBITDA Margin SCHOTT Pharma Guidance FY 2025
BRIEF published on 06/11/2025 at 08:55, 1 year 2 months ago SCHOTT Pharma Extends CEO Contract and Appoints New CFO Global Expansion CEO Contract Extension Innovative Leadership New CFO Appointment Pharmaceutical Containment
PRESS RELEASE published on 06/11/2025 at 08:50, 1 year 2 months ago SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO SCHOTT Pharma extends CEO's contract Andreas Reisse & appoints Reinhard Mayer as CFO. Strategic personnel changes at SCHOTT Pharma AG & Co. KGaA CFO Appointment SCHOTT Pharma Personnel Changes CEO Contract Reinhard Mayer
BRIEF published on 06/04/2025 at 15:35, 1 year 2 months ago SCHOTT Pharma Expands Sterile Cartridge Production in Hungary Expansion Pharmaceutical SCHOTT Pharma Hungary Sterile Cartridges
PRESS RELEASE published on 06/04/2025 at 15:30, 1 year 2 months ago SCHOTT Pharma invests in sterile cartridge production in Hungary SCHOTT Pharma invests over EUR 100 million in new sterile cartridge production facility in Hungary to meet market demand for high-value solutions Expansion Investment SCHOTT Pharma Hungary Sterile Cartridge Production
Published on 08/12/2026 at 09:01, 2 hours 34 minutes ago Apex Drills 4.48% REO Over 8.0 m and 5.27% REO Over 10.2 m Within Multiple ~ 150 m Intervals of > 2.00 % REO at the Rift Rare Earth Project in SE Nebraska
Published on 08/12/2026 at 08:02, 3 hours 33 minutes ago Southern Energy Corp. Announces Spudding of Cotton Valley Test Well at Williamsburg and Appointment of Market Maker
Published on 08/12/2026 at 08:00, 3 hours 35 minutes ago Galantas Selects Engineering and Mine Planning Contractors for Andacollo Gold Project
Published on 08/12/2026 at 00:00, 11 hours 35 minutes ago Organto Foods Reports Record Second Quarter 2026 Financial Results
Published on 08/11/2026 at 23:40, 11 hours 55 minutes ago RJK Explorations Ltd. Announces Private Placement for Gross Proceeds of up to $100,000
Published on 08/12/2026 at 11:24, 11 minutes ago EQS-Adhoc: STEICO SE: Aiveen Kearney steps down as CEO - Thorsten Leicht appointed Chairman of the Managing Directors (CEO)
Published on 08/12/2026 at 11:05, 30 minutes ago SISQUAL® WFM will deliver Workforce Management (WFM) solution to the Norwegian Police SISQUAL® WFM, with Devoteam as a local partner, has been awarded a major public tender to deliver a Workforce Management (WFM) solution to the Norwegian Poli
Published on 08/12/2026 at 11:00, 35 minutes ago Eleving Group: the recording of 6M 2026 earnings call
Published on 08/10/2026 at 18:00, 1 day 17 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 11:53, 1 day 23 hours ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Published on 08/10/2026 at 11:36, 1 day 23 hours ago GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Published on 08/10/2026 at 09:22, 2 days 2 hours ago Number of shares and voting rights - July 2026 (In French only)
